Search results
Results from the WOW.Com Content Network
Methyl benzoate is an organic compound. It is an ester with the chemical formula C 6 H 5 COOCH 3, sometimes abbreviated as PhCO 2 Me, where Ph and Me are phenyl and methyl, respectively. Its structure is C 6 H 5 −C(=O)−O−CH 3. It is a colorless liquid that is poorly soluble in water, but miscible with organic solvents.
PRL-8-53 is a nootropic substituted phenethylamine that has been shown to act as a hypermnesic drug in humans; it was first synthesized by medical chemistry professor Nikolaus Hansl at Creighton University in the 1970s as part of his work on amino ethyl meta benzoic acid esters.
Halogenation with thionyl chloride gave 4-Bromo-3,5-dimethoxybenzoyl chloride [56518-43-5] (6). Rosenmund reduction gave 4-Bromo-3,5-dimethoxybenzaldehyde [31558-40-4] (7). {Alternatively DIBAL meant that FGI from ester to aldehyde was accomplished in only 1 step}.
Methyl 4-iodobenzoate, or methyl p-iodobenzoate, is an organic compound with the formula IC 6 H 4 COOCH 3. [3] It is the methyl ester of 4-iodobenzoic acid , or may also be viewed as an iodinated derivative of methyl benzoate .
Ethyl ester of α-bromoisovaleric acid (ethyl 2-bromo-3-methylbutyrate) — 20 mg; Phenobarbital — 18.26 mg; Peppermint oil — 1.42 mg; Inactive ingredients: stabilizer, ethanol 96%, purified water. According to the Farmak product label, the composition of 1 tablet is as follows: [7] Ethyl ester of α-bromoisovaleric acid — 12.42 mg
4-Bromo-3,5-dimethoxyamphetamine is a lesser-known psychedelic drug and a substituted amphetamine. It was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 4–10 mg and the duration is listed as 8–12 hours. [1] It produces analgesia, numbness, and reduction of physical feeling. Very little data exists ...
4'-Bromo-4-methylaminorex (4B-MAR, 4'-Br-4-MAR) is a designer drug from the substituted aminorex family, first definitively identified in Austria in January 2022. Its pharmacological activity has not been reported, but it is believed to have stimulant effects.
Bromisoval (), commonly known as bromovalerylurea, is a hypnotic and sedative of the bromoureide group discovered by Knoll in 1907 and patented in 1909. [1] It is marketed over the counter in Asia under various trade names (such as Brovarin [2]), usually in combination with nonsteroidal anti-inflammatory drugs.